3/31
06:45 am
lly
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Neutral
Report
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
3/30
09:17 pm
lly
Franklin Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]
Low
Report
Franklin Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]
3/30
10:43 am
lly
Eli Lilly Is Diving Deeper Into AI Drug Discovery With Expanded Insilico Partnership [Yahoo! Finance]
Low
Report
Eli Lilly Is Diving Deeper Into AI Drug Discovery With Expanded Insilico Partnership [Yahoo! Finance]
3/30
10:30 am
lly
Eli Lilly's CEO Says This Could Be a Game Changer for Its Business [Yahoo! Finance]
Low
Report
Eli Lilly's CEO Says This Could Be a Game Changer for Its Business [Yahoo! Finance]
3/30
09:49 am
lly
Eli Lilly and Company (LLY) had its price target lowered by Guggenheim from $1,168.00 to $1,163.00. They now have a "buy" rating on the stock.
Low
Report
Eli Lilly and Company (LLY) had its price target lowered by Guggenheim from $1,168.00 to $1,163.00. They now have a "buy" rating on the stock.
3/30
09:45 am
lly
Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio [Yahoo! Finance]
Low
Report
Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio [Yahoo! Finance]
3/30
09:44 am
lly
Eli Lilly teams up with Insilico to accelerate AI-powered drug development [Yahoo! Finance]
Low
Report
Eli Lilly teams up with Insilico to accelerate AI-powered drug development [Yahoo! Finance]
3/30
08:05 am
lly
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026 [Yahoo! Finance]
Low
Report
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026 [Yahoo! Finance]
3/30
07:15 am
lly
Eli Lilly's (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer [Yahoo! Finance]
Low
Report
Eli Lilly's (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer [Yahoo! Finance]
3/30
06:57 am
lly
Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact [Yahoo! Finance]
Low
Report
Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact [Yahoo! Finance]
3/29
08:48 pm
lly
Insilico Medicine Announces Global R&D Collaboration with Lilly [Yahoo! Finance]
Low
Report
Insilico Medicine Announces Global R&D Collaboration with Lilly [Yahoo! Finance]
3/29
08:45 pm
lly
Prediction: Buying Pfizer Stock Today Could Set You Up for Life [Yahoo! Finance]
Low
Report
Prediction: Buying Pfizer Stock Today Could Set You Up for Life [Yahoo! Finance]
3/29
04:22 pm
lly
Jefferies Remains a Buy on Eli Lilly and Company (LLY) [Yahoo! Finance]
Low
Report
Jefferies Remains a Buy on Eli Lilly and Company (LLY) [Yahoo! Finance]
3/29
01:09 am
lly
Low
Report
3/28
08:08 pm
lly
Eli Lilly EBGLYSS Data Highlights Long Term AD Potential Beyond Obesity [Yahoo! Finance]
Low
Report
Eli Lilly EBGLYSS Data Highlights Long Term AD Potential Beyond Obesity [Yahoo! Finance]
3/28
03:30 pm
lly
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity [Yahoo! Finance]
Low
Report
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity [Yahoo! Finance]
3/28
03:15 pm
lly
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
Low
Report
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
3/28
06:31 am
lly
1 Reason Eli Lilly Stock Is Still a Buy [Yahoo! Finance]
Low
Report
1 Reason Eli Lilly Stock Is Still a Buy [Yahoo! Finance]
3/28
06:10 am
lly
The experimental drug transforming weight loss, retatrutide [USA TODAY]
Low
Report
The experimental drug transforming weight loss, retatrutide [USA TODAY]
3/27
09:00 am
lly
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
Low
Report
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
3/24
02:40 pm
lly
What Kroger (KR)'s New Zepbound Access and Premium Ice Cream Push Means For Shareholders [Yahoo! Finance]
Low
Report
What Kroger (KR)'s New Zepbound Access and Premium Ice Cream Push Means For Shareholders [Yahoo! Finance]
3/24
12:54 pm
lly
Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF [Yahoo! Finance]
Low
Report
Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF [Yahoo! Finance]
3/24
11:48 am
lly
The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant [Yahoo! Finance]
Low
Report
The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant [Yahoo! Finance]
3/24
10:33 am
lly
With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize [Yahoo! Finance]
Low
Report
With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize [Yahoo! Finance]
3/24
09:23 am
lly
Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer [Yahoo! Finance]
Low
Report
Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer [Yahoo! Finance]